Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-group, controlled trial.
Sajad KhialiMohammadreza Taban-SadeghiParvin SarbakhshNaser Khezerlouy-AghadamTaher Entezari-MalekiPublished in: European journal of clinical pharmacology (2023)
Clinical trial ID: IRCT20111206008307N39. Registration date: 27 October 2022. https://www.irct.ir/trial/66216.
Keyphrases
- ejection fraction
- st elevation myocardial infarction
- aortic stenosis
- clinical trial
- study protocol
- open label
- phase ii
- phase iii
- double blind
- left ventricular
- percutaneous coronary intervention
- randomized controlled trial
- acute myocardial infarction
- placebo controlled
- heart failure
- acute coronary syndrome
- transcatheter aortic valve replacement
- cardiac resynchronization therapy
- mitral valve
- atrial fibrillation
- left atrial